IL22RA2 and neoplasm: In colon cancer, activation of NLRP3 functions as a tumor suppressor by mediating the production of IL-18, which reinforces the killing activity of natural killer cells against metastatic tumor cells or down-regulates IL-22BP to suppress tumorigenesis (10, 11).